Significant interest in recent years has focused on gut microbiota–host interaction because
accumulating evidence has revealed that intestinal microbiota play an important role in …

Intestinal microbiota are involved in the pathogenesis of Crohn's disease, ulcerative colitis,
and pouchitis. We review the mechanisms by which these gut bacteria, fungi, and viruses …

Triptolide (TP), a traditional Chinese medicine, has been reported to be effective in the
treatment of autoimmune diseases and exerting antineoplastic activity in several human …

Fecal microbiota transplantation (FMT) is an emerging therapy for recurrent or refractory
Clostridioides difficile infection and is being actively investigated for other conditions. We …

In the twenty first century, the changing epidemiology of inflammatory bowel disease (IBD)
globally with increasing disease incidence across many countries relates to the altered gut …

Ulcerative colitis (UC) is an inflammatory disease that mainly affects the colon and rectum. It
is believed that genetic factors, host immune system disorders, intestinal microbiota …

Fecal microbiota transplantation (FMT) is a method to directly change the recipient's gut
microbiota to normalize the composition and gain a therapeutic benefit. The history of FMT …

Developments in high-throughput microbial genomic sequencing and other systems biology
techniques have given novel insight into the potential contribution of the gut microbiota to …

The community of microorganisms within the human gut (or microbiota) is critical to health
and functions with a level of complexity comparable to that of an organ system. Alterations of …

OBJECTIVES: Patients who are immunocompromised (IC) are at increased risk
ofClostridium difficileinfection (CDI), which has increased to epidemic proportions over the …